(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MINERVA THE UTERINE HEALTH COMPANY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MINERVA THE UTERINE HEALTH COMPANY

ST13

US500000090295783

Class

10, 16, 41

Filing

90295783

Registration

6662585

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

03/08/2022

Trademark type

Combined

Nice classes

10, 16, 41

Filing date

11/03/2020

Registration date

03/08/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/08/2022

Last transaction

03/08/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/17/2021

First use in commerce

09/17/2021

Drawing code

3

Owner type

03

Owner location

Santa Clara, CA, US

Examiner

STEEL, ALYSSA PALADINO

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "MINERVA", with the letter "V" in "MINERVA" formed by two semi-circles with the curved sides facing inward. Below "MINERVA" is the wording "THE UTERINE HEALTH COMPANY".

Holders and representatives

Holders

Minerva Surgical, Inc.

Representatives

Jason W. Burgmaier SEAGER, TUFTE & WICKHEM LLP

Technical classification

Nice Classes

Class 10Class 16Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medical devicessurgical devices that facilitate ablation of biological tissues and resection of biological tissues

Class 16

Printed training materials in the field of using surgical devices that facilitate ablation of biological tissues and resection of biological tissues

Class 41

Providing training on use of medical devices and distribution of training material in connection therewith

Publications

History of USPTO decisions and trademark events.

27 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

03/08/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/21/2021

PUBO

PUBLISHED FOR OPPOSITION

12/21/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/01/2021

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

11/16/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/15/2021

IUAA

USE AMENDMENT ACCEPTED

11/15/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/12/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/12/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/12/2021

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

11/12/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/01/2021

GNRT

NON-FINAL ACTION E-MAILED

10/01/2021

CNRT

NON-FINAL ACTION WRITTEN

10/01/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/01/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/01/2021

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

09/29/2021

IUAF

USE AMENDMENT FILED

09/29/2021

EAAU

TEAS AMENDMENT OF USE RECEIVED

09/28/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/28/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/01/2021

GNRT

NON-FINAL ACTION E-MAILED

04/01/2021

CNRT

NON-FINAL ACTION WRITTEN

04/01/2021

DOCK

ASSIGNED TO EXAMINER

03/29/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/01/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/31/2020

NWAP

NEW APPLICATION ENTERED

11/06/2020

Continuous trademark protection

Get notified about every new filing that threatens MINERVA THE UTERINE HEALTH COMPANY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.